FDA Focus On Food Safety Regulations May Delay OTC And Supplement Rules
This article was originally published in The Tan Sheet
Executive Summary
FDA will try to eke out rules on OTC drug reviews and supplement labels in 2012 with its hands full implementing the food safety act. In the latest regulatory agenda, FDA priorities include an NPRM on foreign supplier verification and regulations to accredit third-party auditors to inspect firms across the agency’s oversight.
You may also be interested in...
Mandatory, Voluntary Recalls Distress Supplement Firms
Because a consent decree stipulated FDA could order Kabco Pharmaceuticals to recall products if the firm was found in violation, the enforcement did not emanate from the agency’s mandatory recall authority. Purity First Products, meanwhile, argues that FDA wrongly claimed the firm refused to conduct a recall.
Mandatory, Voluntary Recalls Distress Supplement Firms
Because a consent decree stipulated FDA could order Kabco Pharmaceuticals to recall products if the firm was found in violation, the enforcement did not emanate from the agency’s mandatory recall authority. Purity First Products, meanwhile, argues that FDA wrongly claimed the firm refused to conduct a recall.
Mandatory, Voluntary Recalls Distress Supplement Firms
Because a consent decree stipulated FDA could order Kabco Pharmaceuticals to recall products if the firm was found in violation, the enforcement did not emanate from the agency’s mandatory recall authority. Purity First Products, meanwhile, argues that FDA wrongly claimed the firm refused to conduct a recall.